Related Experiment Video

Updated: Jun 8, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

[Experience in treating patients with malignant pleural mesothelioma]

Hidetaka Uramoto1, Hidehiko Shimokawa, Tetsuro Baba

  • 1Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Japan.

Journal of UOEH
|September 23, 2010
PubMed

Insights

Multimodality treatment significantly improves survival for malignant pleural mesothelioma patients. Combining chemotherapy, radiotherapy, and surgery offers a better prognosis than single-modality approaches.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Research

Context:

  • Malignant pleural mesothelioma is a rare and aggressive cancer.
  • Treatment outcomes for this condition have historically been poor.
  • Understanding the impact of different treatment modalities is crucial.

Purpose:

  • To analyze the treatment outcomes of patients with malignant pleural mesothelioma.
  • To evaluate the effectiveness of various therapeutic interventions, including surgery, chemotherapy, and radiotherapy.
  • To identify factors associated with improved survival rates.

Summary:

  • A retrospective analysis of 28 malignant pleural mesothelioma patients treated between 1993 and 2009.
  • Patients received treatments including extrapleural pneumonectomy, pleural biopsy, systemic chemotherapy, and radiotherapy.
  • The 2-year survival rate was 25.7%; multimodality treatment showed significantly higher survival than single-modality approaches.

Impact:

  • Multimodality treatment, incorporating chemotherapy and/or radiotherapy with surgery, is associated with a favorable prognosis.
  • Findings suggest that a combined therapeutic strategy should be considered for malignant pleural mesothelioma.
  • This research contributes to optimizing treatment protocols for this challenging cancer.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: